These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3095916)

  • 1. Effects of norfloxacin on the faecal flora in patients with complicated urinary tract infections.
    Boerema JB; Olthof BJ; van Saene HK
    Scand J Infect Dis Suppl; 1986; 48():27-31. PubMed ID: 3095916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norfloxacin treatment in complicated urinary tract infection.
    Boerema JB; van Saene HK
    Scand J Infect Dis Suppl; 1986; 48():20-6. PubMed ID: 3465030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of norfloxacin, trimethoprim-sulfamethoxazole and nitrofurantoin on fecal flora of women with recurrent urinary tract infections.
    Mavromanolakis E; Maraki S; Samonis G; Tselentis Y; Cranidis A
    J Chemother; 1997 Jun; 9(3):203-7. PubMed ID: 9210003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of an amoxicillin-clavulanic acid combination on the aerobic fecal flora in children].
    Borderon JC; Rastegar A; Rolland JC; Laugier J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):569-72. PubMed ID: 3937129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical studies of norfloxacin in urinary tract infections].
    Matsuura T; Kurita T
    Hinyokika Kiyo; 1985 Nov; 31(11):2085-9. PubMed ID: 4091145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manipulation of the oropharyngeal and intestinal microflora by norfloxacin: microbiological and clinical aspects.
    Edlund C; Nord CE
    Scand J Infect Dis Suppl; 1988; 56():14-21. PubMed ID: 3074461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of norfloxacin in complicated and recurrent urinary tract infections.
    Schaeffer AJ
    Eur Urol; 1990; 17 Suppl 1():19-23. PubMed ID: 2191865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Principles for targeted antibiotic use in urinary tract and enteric infections: a review with special emphasis on norfloxacin.
    Norrby SR
    Scand J Infect Dis Suppl; 1986; 48():7-19. PubMed ID: 3535056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative trial of norfloxacin and macrocrystalline nitrofurantoin (Macrodantin) in the prophylaxis of recurrent urinary tract infection in women.
    Brumfitt W; Hamilton-Miller JM; Smith GW; al-Wali W
    Q J Med; 1991 Oct; 81(294):811-20. PubMed ID: 1801054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative evaluation of norfloxacin and cinoxacin in the therapy of complicated infections of the urinary tract].
    Cristiano P; Morelli G; Simioli F; Iovene MR; Della Vittoria Scarpati M; Manguso L
    Minerva Med; 1989 Apr; 80(4):393-5. PubMed ID: 2657499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of norfloxacin preparation in treatment of bacterial infections of the urinary tract in patients with various kidney diseases].
    Mazanowska O; Boratyńska M; Mróz E; Starek J
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):154-7. PubMed ID: 8090671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men.
    Sabbaj J; Hoagland VL; Cook T
    Scand J Infect Dis Suppl; 1986; 48():48-53. PubMed ID: 3490684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressive therapy with norfloxacin in patients with recurrent and/or complicated urinary tract infection.
    Falck L; Bucht H; Stegmayr B; Svärd R
    Scand J Urol Nephrol Suppl; 1988; 110():307-11. PubMed ID: 3055255
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bacterial flora and its sensitivity to antibiotics in urinary tract infections in children].
    Szozda G; Nowakowska K
    Probl Med Wieku Rozwoj; 1984; 13():59-67. PubMed ID: 6442420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reservoir for bacteria of urinary tract infections in urologic patients (author's transl)].
    Ringelmann R; Opara H; Matouschek E
    Immun Infekt; 1977 Apr; 5(2):58-61. PubMed ID: 404234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of aztreonam on the fecal aerobic flora in children].
    Borderon JC; Rastegar A; Ramponi N; Gold F; Laugier J
    Pathol Biol (Paris); 1987 May; 35(5):665-8. PubMed ID: 3112714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of ceftriaxone on aerobic fecal flora in children].
    Borderon JC; Rastegar A; Saliba E; Laugier J; Despert F
    Pathol Biol (Paris); 1990 Sep; 38(7):716-8. PubMed ID: 2235086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic consumption and faecal bacterial susceptibility in surgical in-patients.
    Andåker L; Kling PA; Burman LG
    Acta Chir Scand; 1987; 153(7-8):411-6. PubMed ID: 3673450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norfloxacin versus parenteral therapy in the treatment of complicated urinary tract infections and resistant organisms.
    Cherubin C; Stilwell S
    Scand J Infect Dis Suppl; 1986; 48():32-7. PubMed ID: 3535053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pefloxacin: clinical experience].
    Bertrand A; Janbon F; Jourdan J; Jonquet O; Santoni A
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):596-9. PubMed ID: 3937133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.